Fig. 2From: Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label studyUPDRS I-III and FM score of 15 patients at W-24, W0, W12 and W 24. Each line in the figure represented an individualBack to article page